Skip to content
Recall Observatory FDA recall evidence

Drug product

Doxycycline Capsules, USP, 100 mg, 50-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-616-50.

D-1033-2020

March 13, 2020

Class II

Product summary

Firm
Sun Pharmaceutical Industries, Inc.
Event
Event 85230
Status
Terminated
Classification
Class II
Quantity
172,320 bottles
Official record key
drug-enforcement:D-1033-2020

Official wording

Reason: CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.

Code information: Lot #: 3983720, Exp 10/2020; 3990461, 3990464, 3990465, 3990466, 3990470, Exp 11/2020; AA42499, AA42510, AA44468, AA44470, Exp 04/2021; AA55073, AA55074, AA55075, Exp 05/2021; AA61486, Exp 06/2021

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations